标题
Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway
作者
关键词
-
出版物
CYTOKINE
Volume 141, Issue -, Pages 155429
出版商
Elsevier BV
发表日期
2021-02-10
DOI
10.1016/j.cyto.2021.155429
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CKLF1 Enhances Inflammation-mediated Carcinogenesis and Prevents Doxorubicin-induced Apoptosis via IL-6/STAT3 Signaling in HCC
- (2019) Fan Zhu et al. CLINICAL CANCER RESEARCH
- CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4
- (2019) Chen Chen et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Progress in pharmacological research of chemokine like factor 1 (CKLF1)
- (2018) Dan-Dan Liu et al. CYTOKINE
- CAAT/enhancer binding protein-homologous protein deficiency attenuates liver ischemia/reperfusion injury in mice
- (2018) Seidai Wada et al. LIVER TRANSPLANTATION
- Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice
- (2018) Thiago Henrique Caldeira de Oliveira et al. Frontiers in Immunology
- Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway
- (2017) Nanxin Zheng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia–reperfusion injury
- (2017) Mian Ge et al. Cell Death & Disease
- The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy
- (2017) Dongwei Xu et al. Cell Death & Disease
- The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity
- (2017) Shizan Xu et al. Scientific Reports
- C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury
- (2017) Chiou-Mei Lee et al. Scientific Reports
- C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis
- (2017) Yi Zheng et al. Scientific Reports
- CCL2–CCR2 signaling promotes hepatic ischemia/reperfusion injury
- (2016) Junbin Zhang et al. JOURNAL OF SURGICAL RESEARCH
- Inhibition of chemokine-like factor 1 improves blood-brain barrier dysfunction in rats following focal cerebral ischemia
- (2016) Ling-Lei Kong et al. NEUROSCIENCE LETTERS
- Inhibition of chemokine-like factor 1 protects against focal cerebral ischemia through the promotion of energy metabolism and anti-apoptotic effect
- (2014) Ling Lei Kong et al. NEUROCHEMISTRY INTERNATIONAL
- Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)
- (2011) Yi Zheng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat
- (2011) Ling-Lei Kong et al. NEUROSCIENCE LETTERS
- C19, a C-terminal peptide of chemokine-like factor 1, protects the brain against focal brain ischemia in rats
- (2011) Ling-Lei Kong et al. NEUROSCIENCE LETTERS
- Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice
- (2008) Satoshi Kuboki et al. HEPATOLOGY
- Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4
- (2007) Ying Wang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search